Literature DB >> 1713405

Measurement of serum granulocyte colony-stimulating factor in a patient with congenital agranulocytosis (Kostmann's syndrome).

L Glasser1, B R Duncan, J J Corrigan.   

Abstract

A 12-month-old boy with Kostmann's syndrome was admitted with cavitary pulmonary disease. He had also had bacterial conjunctivitis, periorbital cellulitis, pneumonitis, and otitis media since the age of 10 days. His umbilical cord had not fallen off until he was 3 weeks old. Neutropenia was diagnosed at 4 weeks of age. Antineutrophil antibody studies were negative. A bone marrow aspirate showed granulocytic hypoplasia and a maturation arrest at the promyelocyte stage. Hematopoietic cell culture showed normal numbers of colony-forming units-granulocyte macrophage. Serum granulocyte-macrophage colony-stimulating factor level, was 0.24 ng/mL (normal, greater than 0.05 ng/mL). Serum granulocyte colony-stimulating factor levels, measured by enzyme immunoassay, were undetectable. The patient was successfully treated with filgrastim (granulocyte colony-stimulating factor), with an increase in the absolute neutrophil count to 10.0 x 10(9)/L. Thus, our case of Kostmann's syndrome appears to represent a defect in regulation or production of granulocyte colony-stimulating factor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713405     DOI: 10.1001/archpedi.1991.02160080103029

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  4 in total

Review 1.  Neutrophil elastase in cyclic and severe congenital neutropenia.

Authors:  Marshall S Horwitz; Zhijun Duan; Brice Korkmaz; Hu-Hui Lee; Matthew E Mealiffe; Stephen J Salipante
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

2.  A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments GCSF proliferation activity but not through the MAP kinase cascade.

Authors:  Toshihiro Yokoyama; Seiichi Okamura; Yoshinobu Asano; Kenjirou Kamezaki; Akihiko Numata; Haruko Kakumitsu; Koutarou Shide; Hitoshi Nakashima; Kanaji Taisuke; Yuichi Sekine; Yumi Mizuno; Jun Okamura; Tadashi Matsuda; Mine Harada; Niho Yoshiyuki; Kazuya Shimoda
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

3.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

4.  Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.

Authors:  M H Hermans; C Antonissen; A C Ward; A E Mayen; R E Ploemacher; I P Touw
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.